Jeffrey B. Mirviss

EVP&Pres, Periph Intervent

Jeffrey B. Mirviss (EVP&Pres, Periph Intervent) filed 4 Form 4 reports in the past 24 months (0 purchases, 4 sales), most often in Boston Scientific Corporation (BSX). The largest single filing was $1.4M of BSX (13,022 sh × $105.06, as filed), executed Feb 12 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.9M

shares × price, as filed

Last traded

Feb 25 2025

Filed Feb 25 2025

Median ADV $938.4M across their filed names

Open performance→

Volume by month

Buys $0 Sells $2.9M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 24 months

Most traded names

BSX

Boston Scientific Corporation BSX · 0 buys · 4 sells 4 filings

Recent filings

BSXSALE Boston Scientific Corporation View filing → $767K
7,363 sh across 2 lots
Exec Feb 24 2025
Filed Feb 25 2025 · 5:30 PM ET BSXSALE Boston Scientific Corporation View filing → $159K
1,510 sh × $105.35
Exec Feb 19 2025
Filed Feb 19 2025 · 5:30 PM ET BSXSALE Boston Scientific Corporation View filing → $1.4M
13,022 sh × $105.06
Exec Feb 12 2025
Filed Feb 13 2025 · 5:30 PM ET BSXSALE Boston Scientific Corporation View filing → $643K
7,152 sh × $89.86
Exec Jan 3 2025
Filed Jan 3 2025 · 5:30 PM ET